<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20260521069477N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-06-11</date_registration>
      <primary_sponsor>Iran University of Medical Sciences</primary_sponsor>
      <public_title>The effect of a four-steps treatment programme in the treatment of athletes with low back pain</public_title>
      <acronym></acronym>
      <scientific_title>Investigating the effect of a four-steps programme on pain, functional disability, and postural control in elite athletes with chronic non-specific low back pain; a randomized controlled trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-05-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>42</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/90284</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: This study is a phase III (superiority) single-center, randomized controlled clinical trial with a 1:1 randomization ratio. To reduce selection bias and ensure a uniform distribution of participant characteristics across study groups, a block randomization method with a block size of 4 will be used. The sequence of randomization will be determined by an independent investigator (not involved in the assessment and treatment process) using Random Allocation Software (version 2.0). The randomization codes will be placed in opaque, sealed envelopes and opened in the order in which subjects enter the study, Blinding description: Given the study design and the presence of an intervention group and sham treatment, sham interventions will be administered in a manner as similar as possible to the intervention group so that participants feel the same way about the duration of treatment, therapist placement, and taping (kinesio taping), and are blinded to whether their treatment is real or not. In order to reduce bias, allocation concealment and blinding of participants will be performed.</study_design>
      <phase>3</phase>
      <hc_freetext>Chronic Non-specific Low Back Pain.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: The intervention will be carried out for 6 weeks, with two sessions per week (each session approximately 45 to 60 minutes) and at least 48 hours between sessions. The intervention phases in the four-phase group of the four-phase treatment (Test–Trigger–Tape–Train) are based on specific assessment, tissue release, movement modification and exercise training. This method is designed to improve postural function, reduce pain and functional disability in patients with chronic non-specific low back pain. 1. Test phase (functional and structural assessment) At the beginning of each session, the participant stands upright. During the baseline test, maximum forward bending of the trunk and maximum straightening of the trunk are performed to record baseline values ​​of pain intensity. The most painful trunk movement (highest VAS pain score) is selected as the reference test and the direction that causes the least pain will be considered as the preferred direction (lowest VAS pain score). The reference test is used to examine the effect of skin and underlying fascia displacement on VAS pain and range of motion. The SKD itself will consist of four steps. (1) A lumbodorsal SKD will be performed in a medial-lateral direction to the right and left at the level of the L3, S2, T12, T9, and T4 vertebrae. Next, (2) an oblique SKD will be performed in a cephalo-caudal direction over the latissimus dorsi muscle. Then, (3) an anterior-posterior SKD over the ilium, and finally (4) a cephalo-caudal SKD over the lumbar spine. The severity of the SKD is greater than the degree of laxity of the skin and underlying fascia, equivalent to a grade 4 on the Maitland Passive Tissue Tension Rating Scale. The direction of the SKD that resulted in the most significant improvement in terms of VAS pain reduction and trunk range of motion will be selected as the “positive” direction and will be considered the best Trigger and Tape direction. After performing the Test, Trigger and Tape in one segment, then the steps are performed in the next segments and different SKD directions and we continue the steps until we have the best result. It should be noted that when the reference test without SKD showed the most positive result in terms of pain and/or trunk range of motion, “no intervention” is necessary in that location. 2. Trigger phase (myofascial release) At the desired location, a set of Triggers is applied, in a standing position with slight forward bending (approximately 60 degrees) and posterior rotation of the pelvis, while the patient is leaning forward towards the physiotherapy table. Then the fascia and muscle release is performed using the fist and adduction method. Next, spinal mobilization (grade 4) is performed to mobilize the spine in the preferred direction and the positive direction of SKD. While the patient is in a standing position, the inner part of the palm is placed in the posterior arch and the fifth finger will be placed approximately on the transverse process of the affected segment. The physiotherapist will assess the degree of laxity of the spine in the direction of SKD and ask the patient to take a deep breath, then hold the breath for 4 seconds. During exhalation, joint mobilization will be performed by moving the affected segment in the direction of SKD, which is held for 4 seconds and repeated 4 consecutive times. After spinal mobilization, elastic tape will be applied in the positive medial-lateral SKD direction at L3 while the patient is bent forward towards the physiotherapy table. 3. Tape Phase (Sports Taping) Sports taping will be applied in the positive SKD direction with the fascia displacement technique using approximately 20 cm of elastic tape (At Sport Tape®). For example, at the L3 level, the beginning (¼) of the elastic tape will be applied to the skin approximately 7 cm in the direction lateral to the L3 spinous process. The skin and underlying fascia are then simultaneously applied with the elastic tape (¾) with medium-high pressure in the opposite direction, with the aim of aligning, displacing and stretching the tissues under the tape in the direction of the SKD. The reference test with the tape will then be repeated to assess the effect of the fascial release techniques. The entire procedure will then be performed at the next site (test, trigger and tape) until the most painful direction of trunk movement reaches the acceptable pain level required to perform the exercise. 4. Train phase (functional exercises and postural control) Exercises are performed in the positive direction with the least pain obtained from the baseline test (preferred direction). The total training time is 30 minutes. The training program consisted of a 10-minute warm-up followed by muscular endurance training, muscular strength resistance training, flexibility training, and motor control training. The exercises were divided into 2 programs in the preferred direction: (1) a forward bending training program, which included the recumbent bicycle, Pilates Child pose, and Pilates Half rollback; or (2) a straight training program, which included the Crosstrainer, Pilates Low or High Puppy, and Pilates Breaststroke. A 60-second rest period was included between sets, as recommended by Schoenfeld et al. Intervention 2: Control group: Control group: For participants in the sham four-step treatment group, myofascial release and taping will be performed sham and they will only perform the exercises of recumbent bicycle, half rollback (Pilates), child pose (Pilates), stationary bicycle, breaststroke (Pilates), low or high puppy (Pilates), and crosstrainer. The duration, number of sessions, and supervision are the same in both groups to control for the variable effect of time and therapist focus.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Raw research data and its analysis will be made available to researchers upon request.

When:
After 6 months from the date of publication

To whom:
The data will be available to physiotherapists working on low back pain in academic organisations as well as in the clinic.

Conditions:
The raw data and results of this study can be used for future systematic reviews. Therefore, the raw data and results of this study will be available to researchers working in the field of low back pain.

Where to obtain:
Applicants can contact physiotherapist Alireza Yaseri Gohari via email. Email address: ayaseript@gmail.com

How to obtain:
Applicants should explain in detail about their project and how the data/documents from this study will be used in their project. The data/document files will then be sent to the applicants via email upon request. This process may take 10-12 business days.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mohammadreza Pourahmadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Mirdamad, Madar Square, Shah Nazari Street, Madadkaran Street, Faculty of Rehabilitation Sciences, Iran University of Medical Sciences</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۱۳۴۸۷ ۱۵۴۵۹</zip>
        <telephone>+98 21 2640 5626</telephone>
        <email>pourahmadipt@gmail.com</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Alireza Yaseri Gohari</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Mirdamad, Madar Square, Shah Nazari Street, Madadkaran Street, Faculty of Rehabilitation Sciences, Iran University of Medical Sciences</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۱۳۴۸۷ ۱۵۴۵۹</zip>
        <telephone>+98 21 2640 5626</telephone>
        <email>ayaseript@gmail.com</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Diagnosis of chronic non-specific low back pain: Pain or discomfort in the area between the twelfth rib and the inferior gluteal fold that has been present for at least 3 consecutive months and for which a specific origin (such as a herniated disc or fracture) has not been identified.
Elite athlete: An elite athlete is someone who exercises more than 10 hours per week and whose athletic performance has reached the highest level of competition (e.g., members of a regional or national team, Olympic athletes, professional athletes, and some college athletes).
Age between 18 and 55
No evidence of visible structural lesion on imaging (MRI or X-ray): The diagnosis of chronic nonspecific low back pain is made solely based on clinical criteria and exclusion of specific injuries.
Understanding and ability to follow instructions and fully cooperate during the study (signing an informed consent form and sufficient familiarity with Persian or English).
Not participating in any similar exercise or treatment program in the last 6 weeks.</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>55 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Presence of specific spinal injuries such as herniated discs, spondylolisthesis, vertebral fractures, or spinal infections
Presence of neurological or systemic diseases (such as multiple sclerosis, peripheral neuropathy, uncontrolled diabetes) that can affect postural control or pain perception
History of surgery in the back or lower extremities within the past year
Continuous use of anti-inflammatory or muscle relaxant medications during the study
Pregnancy or menstruation in the acute phase (for female participants) due to hormonal changes affecting postural control
Failure to complete treatment sessions or insufficient cooperation during the intervention period or assessments (more than two missed sessions)
New injury or acute pain during the intervention that makes it impossible to continue participating in the study
Severe motion artifacts or technical problems in IMU data that make data analysis impossible</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: The intervention will be carried out for 6 weeks, with two sessions per week (each session approximately 45 to 60 minutes) and at least 48 hours between sessions. The intervention phases in the four-phase group of the four-phase treatment (Test–Trigger–Tape–Train) are based on specific assessment, tissue release, movement modification and exercise training. This method is designed to improve postural function, reduce pain and functional disability in patients with chronic non-specific low back pain. 1. Test phase (functional and structural assessment) At the beginning of each session, the participant stands upright. During the baseline test, maximum forward bending of the trunk and maximum straightening of the trunk are performed to record baseline values ​​of pain intensity. The most painful trunk movement (highest VAS pain score) is selected as the reference test and the direction that causes the least pain will be considered as the preferred direction (lowest VAS pain score). The reference test is used to examine the effect of skin and underlying fascia displacement on VAS pain and range of motion. The SKD itself will consist of four steps. (1) A lumbodorsal SKD will be performed in a medial-lateral direction to the right and left at the level of the L3, S2, T12, T9, and T4 vertebrae. Next, (2) an oblique SKD will be performed in a cephalo-caudal direction over the latissimus dorsi muscle. Then, (3) an anterior-posterior SKD over the ilium, and finally (4) a cephalo-caudal SKD over the lumbar spine. The severity of the SKD is greater than the degree of laxity of the skin and underlying fascia, equivalent to a grade 4 on the Maitland Passive Tissue Tension Rating Scale. The direction of the SKD that resulted in the most significant improvement in terms of VAS pain reduction and trunk range of motion will be selected as the “positive” direction and will be considered the best Trigger and Tape direction. After performing the Test, Trigger and Tape in one segment, then the steps are performed in the next segments and different SKD directions and we continue the steps until we have the best result. It should be noted that when the reference test without SKD showed the most positive result in terms of pain and/or trunk range of motion, “no intervention” is necessary in that location. 2. Trigger phase (myofascial release) At the desired location, a set of Triggers is applied, in a standing position with slight forward bending (approximately 60 degrees) and posterior rotation of the pelvis, while the patient is leaning forward towards the physiotherapy table. Then the fascia and muscle release is performed using the fist and adduction method. Next, spinal mobilization (grade 4) is performed to mobilize the spine in the preferred direction and the positive direction of SKD. While the patient is in a standing position, the inner part of the palm is placed in the posterior arch and the fifth finger will be placed approximately on the transverse process of the affected segment. The physiotherapist will assess the degree of laxity of the spine in the direction of SKD and ask the patient to take a deep breath, then hold the breath for 4 seconds. During exhalation, joint mobilization will be performed by moving the affected segment in the direction of SKD, which is held for 4 seconds and repeated 4 consecutive times. After spinal mobilization, elastic tape will be applied in the positive medial-lateral SKD direction at L3 while the patient is bent forward towards the physiotherapy table. 3. Tape Phase (Sports Taping) Sports taping will be applied in the positive SKD direction with the fascia displacement technique using approximately 20 cm of elastic tape (At Sport Tape®). For example, at the L3 level, the beginning (¼) of the elastic tape will be applied to the skin approximately 7 cm in the direction lateral to the L3 spinous process. The skin and underlying fascia are then simultaneously applied with the elastic tape (¾) with medium-high pressure in the opposite direction, with the aim of aligning, displacing and stretching the tissues under the tape in the direction of the SKD. The reference test with the tape will then be repeated to assess the effect of the fascial release techniques. The entire procedure will then be performed at the next site (test, trigger and tape) until the most painful direction of trunk movement reaches the acceptable pain level required to perform the exercise. 4. Train phase (functional exercises and postural control) Exercises are performed in the positive direction with the least pain obtained from the baseline test (preferred direction). The total training time is 30 minutes. The training program consisted of a 10-minute warm-up followed by muscular endurance training, muscular strength resistance training, flexibility training, and motor control training. The exercises were divided into 2 programs in the preferred direction: (1) a forward bending training program, which included the recumbent bicycle, Pilates Child pose, and Pilates Half rollback; or (2) a straight training program, which included the Crosstrainer, Pilates Low or High Puppy, and Pilates Breaststroke. A 60-second rest period was included between sets, as recommended by Schoenfeld et al.</i_keyword>
      <i_keyword>Control group: Control group: For participants in the sham four-step treatment group, myofascial release and taping will be performed sham and they will only perform the exercises of recumbent bicycle, half rollback (Pilates), child pose (Pilates), stationary bicycle, breaststroke (Pilates), low or high puppy (Pilates), and crosstrainer. The duration, number of sessions, and supervision are the same in both groups to control for the variable effect of time and therapist focus.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain. Timepoint: Before and After Treatment. Method of measurement: Visual Analog Scale.</prim_outcome>
      <prim_outcome>Functional Disability. Timepoint: Before and After Treatment. Method of measurement: Oswestry Disability Index - Iranian Version.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Kinematic parameters of postural control. Timepoint: Before and After Treatment. Method of measurement: Inertial Measurement Unit data.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Iran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2026-05-20</approval_date>
        <contact_name>Research Ethics Committees of School of Rehabilitation Sciences, Iran University of Medical Sciences</contact_name>
        <contact_address>Tehran, Mirdamad, Madar Square, Shah Nazari Street, Madadkaran Street, Faculty of Rehabilitation Sciences, Iran University of Medical Sciences Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
